Late HCC onset after DAAs therapy in patients with SVR: a type D ADR that requires a longer follow-up? By Admin - July 4, 2019 Facebook Twitter Pinterest WhatsApp Linkedin ReddIt Email Print Tumblr Telegram LINE http://ejhp.bmj.com/cgi/content/short/26/4/243?rss=1
